[1] Kamiyama M, Urushihara M, Morikawa T, et al.Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy[J]. Int J Mol Sci, 2013, 14(11):23045-23062. [2] 廖梦阳, 程龙献, 廖玉华. 肾素-血管紧张素系统的回顾[J]. 临床心血管病杂志, 2012, 28(2):83-87. [3] Ruster C, Wolf G. Angiotensin Ⅱ as a morphogenic cytokine stimulating renal fibrogenesis[J]. J Am Soc Nephrol, 2011, 22(7):1189-1199. [4] 孙豪栋, 庞晓斌, 李继扬. 黄芪甲苷生物活性研究进展[J]. 中国药房, 2011, 22(7):657-661. [5] Brown RD, Hilliard LM, Mirabito KM, et al. Reduced sensitivity of the renal vasculature to angiotensin Ⅱ in young rats:the role of the angiotensin type 2 receptor[J]. Pediatr Res, 2014, 76(5):448-452. [6] Mizuiri S, Ohashi Y. ACE and ACE2 in kidney disease[J]. World J Nephrol, 2015, 4(1):74-82. [7] 黄琼珠, 刘潇萌, 黄国全, 等. 艾塞那肽对糖尿病大鼠肾脏损伤的保护作用[J]. 中国应用生理学杂志, 2017, 33(2):128-131,193. [8] Coughlan MT, Sharma K. Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease[J]. Kidney Int, 2016, 90(2):272-279. [9] Zhang F, Sun D, Chen J, et al. Simvastatin attenuates angiotensin Ⅱ-induced inflammation and oxidative stress in human mesangial cells[J]. Mol Med Rep, 2015, 11(2):1246-1251. [10] Nam BY, Paeng J, Kim SH, et al. The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions[J]. Apoptosis, 2012, 17(1):1-13. [11] 马继伟, 王宏天, 刘浩飞, 等. 积雪草对早期糖尿病肾病大鼠TGF-β1表达及相关下游信号的影响[J]. 中国应用生理学杂志, 2018, 34(1):69-73. [12] 邱勇波, 刘锦, 武飞. 黄芪化学成分及药理作用研究进展[J]. 中国疗养医学, 2011, 20(5):435-436. |